-

nihao guest [ sign in / register ]
2024-7-18 17:26:02
Article

Farrukee R, etc.,al. CHARACTERIZATION OF INFLUENZA B VIRUS VARIANTS WITH REDUCED NEURAMINIDASE INHIBITOR SUSCEPTIBILITY. Antimicrob Agents Chemother. 2018 Sep 10..  Abstract  
submitted by kickingbird at Sep, 16, 2018 from Antimicrob Agents Chemother. 2018 Sep 10. (via https://www.ncbi.nlm.nih.gov/pubmed/30201817)
Treatment options for influenza B virus infections are limited to neuraminidase inhibitors (NAIs) which block the neuraminidase (NA) glycoprotein on the virion surface. The development of NAI resistance ...

Khrustalev VV, Khrustaleva TA, Kordyukova LV. Selection and structural analysis of the NY25 peptide - A vaccine candidate from hemagglutinin of swine-origin Influenza H1N1. Microb Pathog. 2018 Sep 7.  Abstract  
submitted by kickingbird at Sep, 16, 2018 from Microb Pathog. 2018 Sep 7 (via https://www.ncbi.nlm.nih.gov/pubmed/30201593)
The aim of this study was to construct a vaccine peptide candidate against pandemic Influenza H1N1 hemagglutinin and to test its structure. With the help of bioinformatic algorithms we showed that the ...

Bouvier NM. The Future of Influenza Vaccines: A Historical and Clinical Perspective. Vaccines (Basel). 2018 Aug 30;6(3)..  Abstract  
submitted by kickingbird at Sep, 16, 2018 from Vaccines (Basel). 2018 Aug 30;6(3). (via https://www.ncbi.nlm.nih.gov/pubmed/30200179)
For centuries, the development of vaccines to prevent infectious disease was an empirical process. From smallpox variolation in Song dynasty China, through the polysaccharide capsule vaccines developed ...

Xiao Y, Nolting JM, Sheng ZM, Bristol T, et al. Design and validation of a universal influenza virus enrichment probe set and its utility in deep sequence analysis of primary cloacal swab surveillance samples of wild birds. Virology 2018;524:182-191..  Abstract  
submitted by kickingbird at Sep, 16, 2018 from Virology 2018;524:182-191. (via https://www.ncbi.nlm.nih.gov/m/pubmed/30212665/)
Influenza virus infections in humans and animals are major public health concerns. In the current study, a set of universal influenza enrichment probes was developed to increase the sensitivity of sequence-based ...

Yang C, Liu X, Gao Q, Cheng T, et al.. The nucleolar protein LYAR facilitates ribonucleoprotein assembly of influenza A virus. J Virol 2018 Sep 12.  Abstract  
submitted by kickingbird at Sep, 16, 2018 from J Virol 2018 Sep 12 (via https://www.ncbi.nlm.nih.gov/m/pubmed/30209172/)
Influenza A viral ribonucleoprotein (vRNP) is responsible for transcription and replication of the viral genome in infected cells and depend on host factors for its functions. Identification of the host ...

Keeler SP, Agapov EV, Hinojosa ME, Letvin AN, et a. Influenza A Virus Infection Causes Chronic Lung Disease Linked to Sites of Active Viral RNA Remnants. J Immunol 2018 Sep 12..  Abstract  
submitted by kickingbird at Sep, 16, 2018 from J Immunol 2018 Sep 12. (via https://www.ncbi.nlm.nih.gov/m/pubmed/30209189/)
Clinical and experimental observations suggest that chronic lung disease is linked to respiratory viral infection. However, the long-term aspect of this relationship is not yet defined using a virus that ...

Jesper J. Madsen, John M. A. Grime, Jeremy S. Ross. Entropic forces drive clustering and spatial localization of influenza A M2 during viral budding. PNAS September 11, 2018 115 (37) E8595-E8603.  Abstract  
submitted by kickingbird at Sep, 14, 2018 from PNAS September 11, 2018 115 (37) E8595-E8603 (via http://www.pnas.org/content/115/37/E8595)
The influenza A matrix 2 (M2) transmembrane protein facilitates virion release from the infected host cell. In particular, M2 plays a role in the induction of membrane curvature and/or in the scission ...

Levene RE, Gaglia MM. Host Shutoff in Influenza A Virus: Many Means to an End. Viruses. 2018 Sep 5;10(9)..  Abstract  
submitted by kickingbird at Sep, 13, 2018 from Viruses. 2018 Sep 5;10(9). (via https://www.ncbi.nlm.nih.gov/pubmed/30189604)
Influenza A virus carries few of its own proteins, but uses them effectively to take control of the infected cells and avoid immune responses. Over the years, host shutoff, the widespread down-regulation ...

Tam YH, Ng TWY, Chu DKW, Fang VJ, Cowling BJ. The effectiveness of influenza vaccination against medically-attended illnesses in Hong Kong across three years with different degrees of vaccine match, 2014-17. Vaccine. 2018 Sep 3.  Abstract  
submitted by kickingbird at Sep, 13, 2018 from Vaccine. 2018 Sep 3 (via https://www.ncbi.nlm.nih.gov/pubmed/30190121)
BACKGROUND: Influenza vaccination is the most effective intervention to prevent influenza virus infections. Vaccine effectiveness (VE) can vary due to factors such as matching between vaccine strains and ...

Meyer D, Shearer MP, Chih YC, Hsu YC, Lin YC. Taiwan´s Annual Seasonal Influenza Mass Vaccination Program-Lessons for Pandemic Planning. Am J Public Health. 2018 Sep;108(S3):S188-S193.  Abstract  
submitted by kickingbird at Sep, 13, 2018 from Am J Public Health. 2018 Sep;108(S3):S188-S193 (via https://www.ncbi.nlm.nih.gov/pubmed/30192663)
Rapid medical countermeasure (MCM) dispensing is an important intervention during a public health emergency. In the United States, MCM planning and exercising efforts have largely focused on dispensing ...

Federici C1, Cavazza M, Costa F, Jommi C. Health care costs of influenza-related episodes in high income countries: A systematic review. PLoS One. 2018 Sep 7;13(9):e0202787.  Abstract  
submitted by kickingbird at Sep, 13, 2018 from PLoS One. 2018 Sep 7;13(9):e0202787 (via https://www.ncbi.nlm.nih.gov/pubmed/30192781)
INTRODUCTION: This study systematically reviews costing studies of seasonal influenza-like illness (ILI) in high-income countries. Existing reviews on the economic impact of ILI do not report information ...

Ryan KA, etc.,al. Cellular immune response to human influenza viruses differs between H1N1 and H3N2 subtypes in the ferret lung. PLoS One. 2018 Sep 7;13(9):e0202675..  Abstract  
submitted by kickingbird at Sep, 13, 2018 from PLoS One. 2018 Sep 7;13(9):e0202675. (via https://www.ncbi.nlm.nih.gov/pubmed/30192789)
Seasonal influenza virus infections cause yearly epidemics which are the source of a significant public health burden worldwide. The ferret model for human influenza A virus (IAV) is widely used and has ...

Loughran ST, etc.,al. Influenza infection directly alters innate IL-23 and IL-12p70 and subsequent IL-17A and IFN-γ responses to pneumococcus in vitro in human monocytes. PLoS One. 2018 Sep 7;13(9):e0203521.  Abstract  
submitted by kickingbird at Sep, 13, 2018 from PLoS One. 2018 Sep 7;13(9):e0203521 (via https://www.ncbi.nlm.nih.gov/pubmed/30192848)
Influenza virus is highly contagious and poses substantial public health problems due to its strong association with morbidity and mortality. Approximately 250,000-500,000 deaths are caused by seasonal ...

van Wijhe M, Ingholt MM, Andreasen V, Simonsen L. Loose Ends in the Epidemiology of the 1918 Pandemic: Explaining the Extreme Mortality Risk in Young Adults. Am J Epidemiol. 2018 Sep 6.  Abstract  
submitted by kickingbird at Sep, 13, 2018 from Am J Epidemiol. 2018 Sep 6 (via https://www.ncbi.nlm.nih.gov/pubmed/30192906)
In the century since the 1918 influenza pandemic, insights have been sought to explain the pandemic's signature pattern of high death rates in young adults and low death rates in the elderly and infants. ...

L´Huillier AG, etc.,al. Cytokine Profiles and Severity of Influenza Infection in Transplant Recipients. J Infect Dis. 2018 Sep 5..  Abstract  
submitted by kickingbird at Sep, 13, 2018 from J Infect Dis. 2018 Sep 5. (via https://www.ncbi.nlm.nih.gov/pubmed/30192949)
Influenza is responsible for significant morbidity after transplantation. We evaluated Th1/Th2 cytokines and IL-10 levels during influenza infection in the post-transplant setting. Sera from 277 transplant ...

Bolduc M, etc.,al. The quest for a nanoparticle-based vaccine inducing broad protection to influenza viruses. Nanomedicine. 2018 Sep 4.  Abstract  
submitted by kickingbird at Sep, 13, 2018 from Nanomedicine. 2018 Sep 4 (via https://www.ncbi.nlm.nih.gov/pubmed/30193813)
Influenza virus infections are a significant public threat and the best approach to prevent them is through vaccination. Because of the perpetual changes of circulating influenza strains, the efficacy ...

McGrath LJ, etc.,al. High-dose influenza vaccine use among patients receiving hemodialysis in the United States, 2010-2013. Vaccine. 2018 Sep 5..  Abstract  
submitted by kickingbird at Sep, 13, 2018 from Vaccine. 2018 Sep 5. (via https://www.ncbi.nlm.nih.gov/pubmed/30195486)
BACKGROUND: Standard influenza vaccines may be of limited benefit to patients with end-stage renal disease (ESRD). These patients may benefit from high-dose influenza vaccine, currently indicated for patients ...

Cheon SH, etc.,al. Genetic evidence for the intercontinental movement of avian influenza viruses possessing North American-origin nonstructural gene allele B into South Korea. Infect Genet Evol. 2018 Sep.  Abstract  
submitted by kickingbird at Sep, 13, 2018 from Infect Genet Evol. 2018 Sep (via https://www.ncbi.nlm.nih.gov/pubmed/30196122)
Avian influenza viruses (AIVs) are genetically separated by geographical barriers, resulting in the independent evolution of North American and Eurasian lineages. In the present study, to determine whether ...

Sun Y, Liu Z, Liu D, Chen J, Gan F. Low-Level Aflatoxin B1 Promotes Influenza Infection and Modulates a Switch in Macrophage Polarization from M1 to M2. Cell Physiol Biochem. 2018 Sep 7;49(3):1110-1126..  Abstract  
submitted by kickingbird at Sep, 13, 2018 from Cell Physiol Biochem. 2018 Sep 7;49(3):1110-1126. (via https://www.ncbi.nlm.nih.gov/pubmed/30196302)
BACKGROUND/AIMS: Swine influenza virus (SIV) is a major pathogen of both animals and humans. Afatoxin B1 (AFB1) is one of the most common mycotoxins in feed and food. However, the central contribution ...

Scott LJ. Peramivir: A Review in Uncomplicated Influenza. Drugs. 2018 Sep 8..  Abstract  
submitted by kickingbird at Sep, 13, 2018 from Drugs. 2018 Sep 8. (via https://www.ncbi.nlm.nih.gov/pubmed/30196350)
Intravenous peramivir (Alpivab?; Rapivab?; Rapiacta?; PeramiFlu?), the most recent globally approved inhibitor of influenza neuraminidase, is indicated for the treatment of uncomplicated influenza in adults ...

7726 items, 20/Page, Page[206/387][|<<] [|<] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [>|] [>>|]

Related Pages:

Browse by Category
Learn about the flu news, articles, events and more
Subscribe to the weekly F.I.C newsletter!


  

Site map  |   Contact us  |  Term of use  |  FAQs |  粤ICP备10094839号-1
Copyright ©www.flu.org.cn. 2004-2024. All Rights Reserved. Powered by FIC 4.0.1
  Email:webmaster@flu.org.cn